| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Sarcoma | Phase 1/Phase 2 | ClinicalTrials |
| Hypoxia | Phase 1 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Adenocarcinoma | Phase 2 | ClinicalTrials |
| Adenocarcinoma | Phase 3 | ClinicalTrials |
| Sarcoma | Phase 2 | ClinicalTrials |
| Pancreatic Neoplasms | Phase 1 | ClinicalTrials |
| Glioblastoma | Phase 2 | ClinicalTrials |
| Adenoma, Islet Cell; Carcinoma; Carcinoma, Renal Cell; Gastrointestinal Stromal Tumors; Neoplasms; Neuroendocrine Tumors | Phase 1 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 1/Phase 2 | ClinicalTrials |
| Hypoxia; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Esophageal Neoplasms | Phase 1 | ClinicalTrials |
CONTENTS